Literature DB >> 10453863

Reproducibility of maximal exercise ergometer testing in patients with cystic fibrosis.

E F McKone1, S C Barry, M X FitzGerald, C G Gallagher.   

Abstract

OBJECTIVES: Exercise testing in patients with cystic fibrosis (CF) has become an important tool in assessing disease severity and predicting overall outcome. The reproducibility of maximal exercise testing was examined in adult subjects with stable CF.
METHODS: Nine subjects with CF underwent a total of three maximal exercise tests carried out under identical circumstances over a 28-day period. Oxygen uptake (VO2), minute ventilation (VE), respiratory frequency (f), heart rate (HR), and arterial oxygen saturation (SaO2) were measured at rest, at end exercise, and at 40% and 70% of maximum workload.
RESULTS: There were no significant differences in these measurements among the three tests. Reproducibility of exercise performance was assessed using the coefficient of variation. The mean within-subject coefficient of variation for test variables at end exercise are as follows: VO2, 6.9%; VE, 6.2%; f, 5.8%; IIR, 3.0%; and SaO2, 1.1%. The mean within-subject coefficient of variation for test variables at 40% and 70% of maximal work rates are as follows: VO2, 5.2% and 4.6%; SaO2, 0.3% and 0.9%; HR, 4.0% and 3%; VE, 5.7% and 6.5%; and f, 5.8% and 7.2%, respectively.
CONCLUSIONS: Variables measured during clinical cycle ergometer exercise testing in adult patients with stable CF are reproducible. No learning effect was found on repeated testing.

Entities:  

Mesh:

Year:  1999        PMID: 10453863     DOI: 10.1378/chest.116.2.363

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  4 in total

1.  Cardiorespiratory fitness on a treadmill in an adult cystic fibrosis population.

Authors:  Ole Torvanger; Audun Os; Ole Henning Skjonsberg; Elisabeth Edvardsen
Journal:  BMJ Open Sport Exerc Med       Date:  2020-08-17

2.  Inability of myalgic encephalomyelitis/chronic fatigue syndrome patients to reproduce VO₂peak indicates functional impairment.

Authors:  Betsy A Keller; John Luke Pryor; Ludovic Giloteaux
Journal:  J Transl Med       Date:  2014-04-23       Impact factor: 5.531

3.  Cardiopulmonary Exercise Test Methodology for Assessing Exertion Intolerance in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

Authors:  Staci Stevens; Chris Snell; Jared Stevens; Betsy Keller; J Mark VanNess
Journal:  Front Pediatr       Date:  2018-09-04       Impact factor: 3.418

4.  Short-term effects of Lumacaftor/Ivacaftor (Orkambi™) on exertional symptoms, exercise performance, and ventilatory responses in adults with cystic fibrosis.

Authors:  Bradley S Quon; Andrew H Ramsook; Satvir S Dhillon; Reid A Mitchell; Kyle G Boyle; Pearce G Wilcox; Jordan A Guenette
Journal:  Respir Res       Date:  2020-06-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.